Form EFFECT Citius Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 2, 2026 4:15 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stars + Honey Brings Its Collagen Protein Bars That Taste Like Dessert to Target Stores Nationwide
- TechMediaBreaks – Xeriant, Inc. (OTCQB: XERI) Advances NEXBOARD Commercialization with Production Run for Builder Evaluations
- GSJJ Integrates Proprietary AI to Lead the Global "Fast Custom" Gift Industry
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share